Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.620NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.620NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.620NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.2.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.2.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDMNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDMNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDMNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GE.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GE.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.2.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.2.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.2.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JC.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JC.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KE.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KE.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.56NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.56NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.56NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JD.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used